We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Pharmacokinetic (PK) and Safety Study of Plasma-derived Human Butyrylcholinesterase Administered Intravenously

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00333515
Recruitment Status : Completed
First Posted : June 5, 2006
Last Update Posted : January 8, 2018
Sponsor:
Collaborator:
DynPort Vaccine Company LLC, A CSC Company
Information provided by (Responsible Party):
Shire ( Baxalta now part of Shire )

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : April 1, 2008
  Study Completion Date : August 1, 2008